The Cys-loop ligand-gated ion channel family includes the GABA-, glycine-, serotonin-, and nicotinergic acetylcholine receptors, which all play important roles in the nervous signal transduction pathway. They are critical targets for e.g. general anesthetics and alcohol, and all consist of five subunits organized around a central pore. Here, we investigate the prokaryotic Gloeobacter violaceus pentameric ligand-gated ion channel (GLIC) that is a homolog to the cysloop superfamily. GLIC has the advantage of having several X-ray structures published, and we have previously used it for several different modeling studies. To better understand the relation between gating and the pore properties if ligand-gated channels in general, we have substituted several amino residues involved in the kinetics of open and closing of the channel, at different pH. We have characterized these substitutions using an in vitro electrophysiological functional assay (proton concentration response curves); expressing the substituted channels in Xenopus laevis oocytes for two-electrode voltage clamp experiments. We have also made single-channel recordings for investigating the kinetics (open, closing, and flickering behavior) of the substitutions, observed in silico. Our results indicate that the hydrophobicity of the pore is critical to determine both the balance and kinetics of the opening/closing process, and it is possible to alter the gating properties of the channel while still keeping it functional. This is an important step in the process of developing more effective anesthetics, with a better therapeutic window, but also to identify a possible molecular mechanism of how to reduce alcohol dependency. Molecular Biophysics, University of Virginia, Charlottesville, Sweden. The prokaryotic Gloeobacter violaceus pentameric ligand-gated ion channel (GLIC) is an important template for studies of Cys-loop receptors in the human central nervous system. It is also a key model system to understand the transitions and stabilization of different conformations of membrane proteins through allosteric modulation -a ligand that opens the channel can either stabilize the open state, or destabilize the closed one. Capturing these processes on the molecular level will not only enable us to understand gating, but also make it possible to predict functional responses rather than merely binding properties. Over the last years, we have studied mutants of the GLIC channel that make it more similar to the human Cys-loop receptors both experimentally and in simulations, and shown how this provides evidence for a dual allosteric modulation mechanism with separate inhibitory and potentiating binding sites. Here, I will present our new results on mutations in the central GLIC pore. By modifying the hydrophobicity of one or several residues in the pore it is possible to alter the pore hydration level, which in turn has paramount effects on the conformation -molecular simulations show that it is possible to stabilize the channel either in the open or closed conformation independent of pH. By using ensemble molecular dynamics simulations covering several tens of microseconds, we show that it is possible to reversibly simulate transitions between conformations that are shown to actually conduct ions or block the current in simulations. In vivo electrophysiology and single-channel recordings on the mutants confirm this influence on the kinetics, and provide us with a way to couple molecular-level dynamics and kinetics to the experimentally observed equilibrium and transitions between conformations. Cardiac Muscle I 1737-Pos Board B467 Effect of Pimobendan on Heart Failure in a Mouse Model Inherited Cardiomyopathy Miki Nonaka, Kengo Hayamizu, Sachio Morimoto. Kyushu University, Fukuoka, Japan. The DK210 mutation in cardiac troponin T causes dilated cardiomyopathy (DCM) in human by impairing cardiac systolic function through a decrease in cardiac myofilament Ca 2þ sensitivity. Knock-in mice on the BALB/c background exhibit progressive heart failure (HF), leading to premature death. In this study, effects of Ca 2þ sensitizer pimobendan on HF were examined using this DCM model. Pimobendan was administered orally once daily at two doses,10 (low dose) and 100 (high dose) mg/kg, at two different stages, 4 weeks old with ejection fraction (EF) of over 35% (compensated stage) and 6-9 weeks old with EF of less than 35% (end-stage). Pimobendan improved life-expectancy at both stages, with a similar effect at low dose. High dose pimobendan further improved it at compensated stage, but had a much less effect than low dose at end-stage due to frequent sudden death. Pimobendan prevented the increase in heart and lung weight in a dose-dependent manner at compensated stage with the increase being almost completely blocked at high dose, whereas it had no effects at end-stage at any dose. Only high dose pimobendan improved HF symptoms such as dyspnea at end-stage and prevented their development at compensated stage. These results suggest that a high dose pimobendan might have beneficial effects to improve life expectancy at compensated stage by preventing the development of HF, but it may conversely impair life-expectancy at end-stage HF by increasing the risk of sudden death. On the other hand, a low dose pimobendan might improve life-expectancy at end-stage HF, although it could not prevent HF even at compensated stage. To clarify the mechanisms by which optimal doses of pimobendan are different in compensated and end-stage HF, investigation of the effect of pimobendan on isolated cardiomyocytes is in progress.
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